hc1, the leader in transforming lab data into actionable intelligence that improves patient health outcomes while boosting the bottom line, is accelerating growth with $6.25 million in new financing after a successful acquisition in October 2024 of Accumen.

Existing investor, Health Cloud Capital, led the investment with participation from health tech investment firm, A1 Health Ventures. Arsenal Capital Partners joined the investor base in the combined platform via its ownership stake in Accumen.